Thiostrepton
Peptide Elongation Factor G
RNA, Ribosomal, 23S
Ribosomes
Streptomyces
Viomycin
Ribosomal Proteins
Fusidic Acid
Puromycin
A detailed view of a ribosomal active site: the structure of the L11-RNA complex. (1/111)
We report the crystal structure of a 58 nucleotide fragment of 23S ribosomal RNA bound to ribosomal protein L11. This highly conserved ribonucleoprotein domain is the target for the thiostrepton family of antibiotics that disrupt elongation factor function. The highly compact RNA has both familiar and novel structural motifs. While the C-terminal domain of L11 binds RNA tightly, the N-terminal domain makes only limited contacts with RNA and is proposed to function as a switch that reversibly associates with an adjacent region of RNA. The sites of mutations conferring resistance to thiostrepton and micrococcin line a narrow cleft between the RNA and the N-terminal domain. These antibiotics are proposed to bind in this cleft, locking the putative switch and interfering with the function of elongation factors. (+info)Thiostrepton-resistant mutants exhibit relaxed synthesis of RNA. (2/111)
Spontaneous mutants of Bacillus subtilis resistant to thiostrepton (TSP) exhibit relaxed synthesis of RNA when starved for required amino acids. Intact cells of tsp mutants cannot synthesize the regulatory nucleotides, ppGpp and pppGpp, after amino acid deprivation. Because ribosomes isolated from spontaneous revertants to thiostrepton sensitivity and from wild-type stringent strains can synthesize (p)ppGpp whereas ribosomes isolated from tsp strains cannot synthesize these regulatory nucleotides in the presence of stringent factor, it appears that the lesion is expressed at the level of the ribosome. Genetic mapping, via three-factor transformational crosses, has shown that tsp is closely linked to rif, in the order cysA14, tsp, rif-I, strA. The phenotype of the tsp mutants indicates that they are of the relC type. Their map position indicates that they are different from a previously described B subtilis rel mutation. Ribosomes from the latter strain can synthesize (p)ppGpp in cell-free extracts. (+info)Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome. (3/111)
The region around position 1067 in domain II of 23S rRNA frequently is referred to as the GTPase center of the ribosome. The notion is based on the observation that the binding of the antibiotic thiostrepton to this region inhibited GTP hydrolysis by elongation factor G (EF-G) on the ribosome at the conditions of multiple turnover. In the present work, we have reanalyzed the mechanism of action of thiostrepton. Results obtained by biochemical and fast kinetic techniques show that thiostrepton binding to the ribosome does not interfere with factor binding or with single-round GTP hydrolysis. Rather, the antibiotic inhibits the function of EF-G in subsequent steps, including release of inorganic phosphate from EF-G after GTP hydrolysis, tRNA translocation, and the dissociation of the factor from the ribosome, thereby inhibiting the turnover reaction. Structurally, thiostrepton interferes with EF-G footprints in the alpha-sarcin stem loop (A2660, A2662) located in domain VI of 23S rRNA. The results indicate that thiostrepton inhibits a structural transition of the 1067 region of 23S rRNA that is important for functions of EF-G after GTP hydrolysis. (+info)Replacement of L7/L12.L10 protein complex in Escherichia coli ribosomes with the eukaryotic counterpart changes the specificity of elongation factor binding. (4/111)
The L8 protein complex consisting of L7/L12 and L10 in Escherichia coli ribosomes is assembled on the conserved region of 23 S rRNA termed the GTPase-associated domain. We replaced the L8 complex in E. coli 50 S subunits with the rat counterpart P protein complex consisting of P1, P2, and P0. The L8 complex was removed from the ribosome with 50% ethanol, 10 mM MgCl(2), 0.5 M NH(4)Cl, at 30 degrees C, and the rat P complex bound to the core particle. Binding of the P complex to the core was prevented by addition of RNA fragment covering the GTPase-associated domain of E. coli 23 S rRNA to which rat P complex bound strongly, suggesting a direct role of the RNA domain in this incorporation. The resultant hybrid ribosomes showed eukaryotic translocase elongation factor (EF)-2-dependent, but not prokaryotic EF-G-dependent, GTPase activity comparable with rat 80 S ribosomes. The EF-2-dependent activity was dependent upon the P complex binding and was inhibited by the antibiotic thiostrepton, a ligand for a portion of the GTPase-associated domain of prokaryotic ribosomes. This hybrid system clearly shows significance of binding of the P complex to the GTPase-associated RNA domain for interaction of EF-2 with the ribosome. The results also suggest that E. coli 23 S rRNA participates in the eukaryotic translocase-dependent GTPase activity in the hybrid system. (+info)The RNA-binding domain of ribosomal protein L11 recognizes an rRNA tertiary structure stabilized by both thiostrepton and magnesium ion. (5/111)
Antibiotics that inhibit ribosomal function may do so by one of several mechanisms, including the induction of incorrect RNA folding or prevention of protein and/or RNA conformational transitions. Thiostrepton, which binds to the 'GTPase center' of the large subunit, has been postulated to prevent conformational changes in either the L11 protein or rRNA to which it binds. Scintillation proximity assays designed to look at the binding of the L11 C-terminal RNA-binding domain to a 23S ribosomal RNA (rRNA) fragment, as well as the ability of thiostrepton to induce that binding, were used to demonstrate the role of Mg(2+), L11 and thio-strepton in the formation and maintenance of the rRNA fragment tertiary structure. Experiments using these assays with both an Escherichia coli rRNA fragment and a thermostable variant of that RNA show that Mg(2+), L11 and thiostrepton all induce the RNA to fold to an essentially identical tertiary structure. (+info)The joining of the 30-S initiation complex with the 50-S subunit, the main target for thiostrepton. (6/111)
The study undertaken in this paper on the mode of action of thiostrepton provides data which permit a more precise localization of the main target of thiostrepton. There is severe impairment of the joining of the 50-S subunit, probably carrying thiostrepton, with either the 30-S subunit or the 30-S initiation complex. The degree of impairment of this coupling is temperature dependent, being almost completely inhibited at 0 degrees C, whereas at 37 degrees C the effect is much less marked, provided that natural messenger RNA is present. The inhibition of initiation by thiostrepton is more severe in the presence of IF-1, a factor, which similar to thiostrepton, is able to shift the dynamic equilibrium of 70-S in equilibrium 50-S + 30-S more towards dissociation. By means of 14C-labeled IF-2 it is demonstrated that the binding of IF-2 into the 70-S initiation complex is prevented by thiostrepton, which seems to be the main cause for non-coupling. (+info)Enhanced production of microbial metabolites in the presence of dimethyl sulfoxide. (7/111)
Bacterial strains grown in the presence of low concentrations of dimethyl sulfoxide (DMSO) exhibit significant qualitative and quantitative alterations in the production of secondary metabolites. This effect was confirmed for a variety of biosynthetic families, including chloramphenicol (chorismate), thiostrepton (peptide) and tetracenomycin (polyketide), and for natural and recombinant strains of streptomycetes; a similar effect was seen with antibiotic-producing bacilli such as B. circulans. Increase in antibiotic production was not the result of a change in the growth rate of these organisms, since yields of biomass were similar in media with and without DMSO (up to 3%). We suggest that the addition of compounds such as DMSO provides a means of examining the full biosynthetic potential of microbes and might be used to promote secondary metabolite production. The mode of action of DMSO is not known, but in the cases studied it may act at the level of translation. (+info)Methylation of basic proteins in ribosomes from wild-type and thiostrepton-resistant strains of Bacillus megaterium and their electrophoretic analysis. (8/111)
Ribosomes, radioactively labelled in vivo with both [1-14C]methionine and [methyl-3H]methionine, have been isolated from both wild-type and thiostrepton-resistant strains of Bacillus megaterium and their constituent proteins separated by two-dimensional gel electrophoresis. Ribosomes from the wild-type strain possess one basic protein that is extensively methylated. In contrast no such protein can be detected in ribosomes from the thiostrepton-resistant strain. (+info)Thiostrepton is an antibiotic and antiproliferative agent that is derived from the bacterium Streptomyces azureus. It belongs to the family of thiostreptons, which are cyclic oligopeptides with unique structures and various biological activities. Thiostrepton has been used primarily in veterinary medicine for the treatment of infections caused by gram-positive bacteria, such as mastitis in cows.
In addition to its antibacterial properties, thiostrepton has also been found to have antiproliferative and proapoptotic effects on various cancer cells, including breast, ovarian, and colon cancer cells. These effects are thought to be mediated by the inhibition of protein synthesis and the regulation of gene expression. However, its use as a therapeutic agent in humans is still being investigated due to its potential toxicity and limited bioavailability.
It's worth noting that thiostrepton is not commonly used in clinical practice, and its medical definition is mainly related to its chemical structure, antibacterial properties, and potential anticancer effects.
Peptide Elongation Factor G is a term used in the field of molecular biology, specifically in the process of protein synthesis. It is a bacterial enzyme that plays a crucial role in the elongation stage of translation, which is the process by which genetic information encoded in messenger RNA (mRNA) is converted into a polypeptide chain or protein.
More specifically, Peptide Elongation Factor G (also known as EF-G or Translocase) is responsible for the translocation step during translation. After each amino acid is added to the growing peptide chain, the mRNA and tRNAs must move relative to the ribosome so that the next codon in the mRNA can be read. EF-G facilitates this movement by using energy from GTP hydrolysis to cause a conformational change in the ribosome, resulting in the translocation of the mRNA and tRNAs by one codon.
In summary, Peptide Elongation Factor G is a bacterial enzyme that plays an essential role in the elongation stage of protein synthesis by facilitating the movement of mRNA and tRNAs relative to the ribosome during translation.
23S Ribosomal RNA (rRNA) is a type of rRNA that is a component of the large ribosomal subunit in both prokaryotic and eukaryotic cells. In prokaryotes, the large ribosomal subunit contains 50S, which consists of 23S rRNA, 5S rRNA, and around 33 proteins. The 23S rRNA plays a crucial role in the decoding of mRNA during protein synthesis and also participates in the formation of the peptidyl transferase center, where peptide bonds are formed between amino acids.
The 23S rRNA is a long RNA molecule that contains both coding and non-coding regions. It has a complex secondary structure, which includes several domains and subdomains, as well as numerous stem-loop structures. These structures are important for the proper functioning of the ribosome during protein synthesis.
In addition to its role in protein synthesis, 23S rRNA has been used as a target for antibiotics that inhibit bacterial growth. For example, certain antibiotics bind to specific regions of the 23S rRNA and interfere with the function of the ribosome, thereby preventing bacterial protein synthesis and growth. However, because eukaryotic cells do not have a 23S rRNA equivalent, these antibiotics are generally not toxic to human cells.
Ribosomes are complex macromolecular structures composed of ribonucleic acid (RNA) and proteins that play a crucial role in protein synthesis within cells. They serve as the site for translation, where messenger RNA (mRNA) is translated into a specific sequence of amino acids to create a polypeptide chain, which eventually folds into a functional protein.
Ribosomes consist of two subunits: a smaller subunit and a larger subunit. These subunits are composed of ribosomal RNA (rRNA) molecules and proteins. In eukaryotic cells, the smaller subunit is denoted as the 40S subunit, while the larger subunit is referred to as the 60S subunit. In prokaryotic cells, these subunits are named the 30S and 50S subunits, respectively. The ribosome's overall structure resembles a "doughnut" or a "cotton reel," with grooves and binding sites for various factors involved in protein synthesis.
Ribosomes can be found floating freely within the cytoplasm of cells or attached to the endoplasmic reticulum (ER) membrane, forming part of the rough ER. Membrane-bound ribosomes are responsible for synthesizing proteins that will be transported across the ER and ultimately secreted from the cell or inserted into the membrane. In contrast, cytoplasmic ribosomes synthesize proteins destined for use within the cytoplasm or organelles.
In summary, ribosomes are essential components of cells that facilitate protein synthesis by translating mRNA into functional polypeptide chains. They can be found in various cellular locations and exist as either free-floating entities or membrane-bound structures.
Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.
Streptomyces is a genus of Gram-positive, aerobic, saprophytic bacteria that are widely distributed in soil, water, and decaying organic matter. They are known for their complex morphology, forming branching filaments called hyphae that can differentiate into long chains of spores.
Streptomyces species are particularly notable for their ability to produce a wide variety of bioactive secondary metabolites, including antibiotics, antifungals, and other therapeutic compounds. In fact, many important antibiotics such as streptomycin, neomycin, tetracycline, and erythromycin are derived from Streptomyces species.
Because of their industrial importance in the production of antibiotics and other bioactive compounds, Streptomyces have been extensively studied and are considered model organisms for the study of bacterial genetics, biochemistry, and ecology.
Viomycin is an antibiotic that belongs to the class of drugs known as aminoglycosides. It works by binding to bacterial ribosomes and interfering with protein synthesis, leading to bacterial cell death. Viomycin is primarily used to treat tuberculosis and other mycobacterial infections that are resistant to other antibiotics. However, its use is limited due to its potential toxicity to the kidneys and hearing.
Here's a medical definition of Viomycin from Stedman's Medical Dictionary:
"A crystalline, basic polypeptide antibiotic produced by certain strains of Streptomyces floridae var. violaceusniger; used in the treatment of tuberculosis and other mycobacterial infections."
Ribosomal proteins are a type of protein that play a crucial role in the structure and function of ribosomes, which are complex molecular machines found within all living cells. Ribosomes are responsible for translating messenger RNA (mRNA) into proteins during the process of protein synthesis.
Ribosomal proteins can be divided into two categories based on their location within the ribosome:
1. Large ribosomal subunit proteins: These proteins are associated with the larger of the two subunits of the ribosome, which is responsible for catalyzing peptide bond formation during protein synthesis.
2. Small ribosomal subunit proteins: These proteins are associated with the smaller of the two subunits of the ribosome, which is responsible for binding to the mRNA and decoding the genetic information it contains.
Ribosomal proteins have a variety of functions, including helping to stabilize the structure of the ribosome, assisting in the binding of substrates and cofactors necessary for protein synthesis, and regulating the activity of the ribosome. Mutations in ribosomal proteins can lead to a variety of human diseases, including developmental disorders, neurological conditions, and cancer.
Fusidic Acid is a steroid antibiotic, derived from the fungus Fusidium coccineum. It is primarily used to treat skin infections and other susceptible bacterial infections. It works by inhibiting bacterial protein synthesis. In medical terms, it can be defined as:
A triterpenoid antibiotic derived from the fungus Fusidium coccineum, used primarily to treat staphylococcal and streptococcal skin infections that are resistant to other antibiotics. It inhibits bacterial protein synthesis by binding to the bacterial elongation factor EF-G, preventing translocation of peptidyl tRNA from the A site to the P site on the ribosome.
It is important to note that resistance to fusidic acid can develop and its use should be reserved for infections caused by organisms known to be susceptible to it. It is not typically used as a first-line antibiotic, but rather as a secondary option when other treatments have failed or are contraindicated.
Puromycin is an antibiotic and antiviral protein synthesis inhibitor. It works by being incorporated into the growing peptide chain during translation, causing premature termination and release of the incomplete polypeptide. This results in the inhibition of protein synthesis and ultimately leads to cell death. In research, puromycin is often used as a selective agent in cell culture to kill cells that have not been transfected with a plasmid containing a resistance gene for puromycin.
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.